Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aldosterone acts via mineralocorticoid receptors (MRs) to control salt and water flux in epithelial organs such as the kidney and colon to maintain circulatory homeostasis. Inappropriate glucocorticoid-mediated activation of MRs in aldosterone-target tissues is prevented by the glucocorticoid-metabolizing enzyme
11beta-hydroxysteroid dehydrogenase type 2
(
HSD2
). We have studied
HSD2
expression in the mouse at the level of gene transcription and further analyzed, with HSD1, its pattern of tissue-restricted gene expression. The mouse
HSD2
gene, including upstream regulatory regions, has been cloned, and its transcription start site has been mapped in colon and kidney. A 2.5 kb upstream region has been sequenced, and its proximal promoter region has been analyzed. We have compared the relative expression of HSD1 and
HSD2
in a variety of tissues from male mice using
ribonuclease
protection analysis. HSD1 was expressed in liver, kidney, adrenal, lung, spleen, thymus, fat, small intestine, stomach, heart, skin, and epididymis.
HSD2
was expressed in kidney, colon, small intestine, stomach, and epididymus. No expression of either HSD1 and
HSD2
was detected in bladder, testis, seminal vesicles, vas deferens, prostate, or skeletal muscle. Finally, to investigate the specific roles of
HSD2
in vivo, we have created "floxed"
HSD2
alleles using gene targeting in mouse embryonic stem cells with the aim to create tissue-specific ablation of
HSD2
in mice via Cre recombinase mediated gene targeting.
...
PMID:Expression of the 11beta-hydroxysteroid dehydrogenase 2 gene in the mouse. 1076 59
Data suggest that mineralocorticoid selectivity is differentially regulated in epithelial target tissues. We investigated whether the level of dietary NaCl intake influenced the expression and tissue distribution of
11-beta-hydroxysteroid dehydrogenase type 2
(11betaHSD-2), aldosterone receptor (MR), and glucocorticoid receptor (GR) in rat colon, kidney, and cardiovascular tissue. Rats were fed a diet with 0.01 or 3% NaCl for 10 days. Messenger RNAs were analyzed with
ribonuclease
protection assay, 11betaHSD-2 protein by Western blot analysis, and localization of GR and 11betaHSD-2 by immunohistochemistry. NaCl restriction elevated plasma renin and aldosterone concentration, whereas corticosterone was unaltered. In distal colon, 11betaHSD-2 mRNA and protein were augmented significantly by low-NaCl intake and immunolabeling was widely distributed in crypt and surface epithelium. The MR mRNA level was decreased, whereas GR mRNA was unaltered in distal colon. MR, GR, and 11betaHSD-2 mRNAs were not changed in kidney cortex and medulla, left cardiac ventricle, and aorta. Immunofluorescence labeling showed that GR and 11betaHSD-2 localization was mutually exclusive in kidney. In colon epithelium, nuclear staining for GR subsided as perinuclear 11betaHSD-2 immunoreactivity increased with NaCl restriction. As a functional correlate of increased 11betaHSD-2 expression in colon, the GR-stimulated sodium-hydrogen exchanger NHE-3 was lowered by NaCl restriction. Inhibition of 11betaHSD-2 activity by carbenoxolone during NaCl restriction stimulated NHE-3 expression in colon. Dexamethasone stimulated NHE-3 both in colon and kidney. These data indicate that mineralocorticoid selectivity is physiologically regulated by NaCl intake at the level of 11betaHSD-2 expression and tissue distribution in the distal colon, but not in the kidney.
...
PMID:Stimulation of 11-beta-hydroxysteroid dehydrogenase type 2 in rat colon but not in kidney by low dietary NaCl intake. 1284 61
Background:
Streptococcus pneumoniae
colonize the human nasopharynx in the form of biofilms. The biofilms act as bacterial reservoirs and planktonic bacteria from these biofilms can migrate to other sterile anatomical sites to cause pneumonia, otitis media (OM), bacteremia and meningitis. Human amniotic membrane contains numerous growth factors and antimicrobial activity; however, these have not been studied in detail. In this study, we prepared amniotic membrane extract and chorionic membrane extract (
AME
/CME) and evaluated their antibacterial and antibiofilm activities against
S. pneumoniae
using an
in vitro
biofilm model and
in vivo
OM rat model.
Materials and Methods:
The
AME
/CME were prepared and protein was quantified using DC
TM
(detergent compatible) method. The minimum inhibitory concentrations were determined using broth dilution method, and the synergistic effect of
AME
/CME with Penicillin-streptomycin was detected checkerboard. The
in vitro
biofilm and
in vivo
colonization of
S. pneumoniae
were studied using microtiter plate assay and OM rat model, respectively. The
AME
/CME-treated biofilms were examined using scanning electron microscope and confocal microscopy. To examine the constituents of
AME
/CME, we determined the proteins and peptides of
AME
/CME using tandem mass tag-based quantitative mass spectrometry.
Results:
AME
/CME treatment significantly (
p
< 0.05) inhibited
S. pneumoniae
growth in planktonic form and in biofilms. Combined application of
AME
/CME and Penicillin-streptomycin solution had a synergistic effect against
S. pneumoniae.
Biofilms grown with
AME
/CME were thin, scattered, and unorganized.
AME
/CME effectively eradicated pre-established pneumococci biofilms and has a bactericidal effect.
AME
treatment significantly (
p
< 0.05) reduced bacterial colonization in the rat middle ear. The proteomics analysis revealed that the
AME
/CME contains hydrolase,
ribonuclease
, protease, and other antimicrobial proteins and peptides.
Conclusion:
AME
/CME inhibits
S. pneumoniae
growth in the planktonic and biofilm states via its antimicrobial proteins and peptides.
AME
/CME are non-cytotoxic, natural human product; therefore, they may be used alone or with antibiotics to treat
S. pneumoniae
infections.
...
PMID:Antimicrobial and Antibiofilm Effects of Human Amniotic/Chorionic Membrane Extract on
Streptococcus pneumoniae
. 2908 28